Cambridge Investment Research Advisors’s VanEck Biotech ETF BBH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $213K | Buy |
|
|||||
|
2024
Q4 | – | Sell |
|
|||||
|
2024
Q3 | $276K | Sell |
|
|||||
|
2024
Q2 | $268K | Sell |
|
|||||
|
2024
Q1 | $281K | Buy |
|
|||||
|
2023
Q4 | $224K | Buy |
|
|||||
|
2023
Q3 | – | Sell |
|
|||||
|
2023
Q2 | $242K | Sell |
|
|||||
|
2023
Q1 | $680K | Sell |
|
|||||
|
2022
Q4 | $1.76M | Buy |
|
|||||
|
2022
Q3 | $1.52M | Sell |
|
|||||
|
2022
Q2 | $1.71M | Sell |
|
|||||
|
2022
Q1 | $2.1M | Buy |
|
|||||
|
2021
Q4 | $478K | Buy |
|
|||||
|
2021
Q3 | $497K | Buy |
|
|||||
|
2021
Q2 | $426K | Sell |
|
|||||
|
2021
Q1 | $408K | Sell |
|
|||||
|
2020
Q4 | $516K | Buy |
|
|||||
|
2020
Q3 | $445K | Sell |
|
|||||
|
2020
Q2 | $508K | Buy |
|
|||||
|
2020
Q1 | $201K | Buy |
|
|||||
|
2018
Q4 | – | Sell |
|
|||||
|
2018
Q3 | $311K | Sell |
|
|||||
|
2018
Q2 | $284K | Sell |
|
|||||
|
2018
Q1 | $317K | Buy |
|
|||||
|
2017
Q4 | $324K | Sell |
|
|||||
|
2017
Q3 | $1.82M | Sell |
|
|||||
|
2017
Q2 | $2.71M | Sell |
|
|||||
|
2017
Q1 | $2.58M | Sell |
|
|||||
|
2016
Q4 | $2.41M | Sell |
|
|||||
|
2016
Q3 | $3.33M | Buy |
|
|||||
|
2016
Q2 | $337K | Buy |
|
|||||
|
2016
Q1 | $295K | Sell |
|
|||||
|
2015
Q4 | $405K | Buy |
|
|||||
|
2015
Q3 | $365K | Sell |
|
|||||
|
2015
Q2 | $564K | Buy |
|
|||||
|
2015
Q1 | $468K | Sell |
|
|||||
|
2014
Q4 | $431K | Buy |
|
|||||
|
2014
Q3 | $369K | Buy |
|
|||||
|
2014
Q2 | $325K | Sell |
|
|||||
|
2014
Q1 | $398K | Buy |
|